We evaluated
the clinical feasibility of the reduced field-of-view diffusion weighted
imaging (rFOV DWI) with computed DWI technique in patients with breast cancer
by performing a comparison and analysis of the inter-method agreement among the
acquired rFOV DWI (rFOVA), rFOV DWI with computed DWI technique (synthetic rFOV
DWI; rFOVS), and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) in patients with breast
cancer. We found that the rFOV DWI and rFOV DWI with computed DWI technique showed nearly
equivalent level of image quality required for analysis of the tumors and
lesion conspicuity compared with DCE MRI.
